Peer-reviewedCC BY-NC-NDTranslational cancer research
Metabolic signature of phosphoethanolamine and arginine pathways predicts prognosis and immunotherapy resistance in lung adenocarcinoma
- 1Department of Medical Oncology , Lanzhou University Second Hospital , Lanzhou , ;
- 2Department of Orthopedics , Lanzhou University Second Hospital , Lanzhou , ;
- 3Department of Integrated Traditional Chinese and Western Medicine Gynecology , Gansu Provincial Maternal and Child Health Hospital , Lanzhou ,
Related
- A T-cell exhaustion-related signature for predicting response to immunotherapy among patients with lung adenocarcinoma
- Epigenetic and metabolic plasticity of tumor cells in immunotherapy resistance
- SPP1⁺ macrophage-derived WNT5A contributes to MMP11⁺ myCAF-mediated matrix remodeling and immunotherapy resistance in lung adenocarcinoma
- Decoding lipid metabolic reprogramming in pancreatic ductal adenocarcinoma: from tumor–microenvironment crosstalk to therapeutic resistance
- PCSK9 drives acquired resistance to anti-PD-1 immunotherapy through cystine metabolic reprogramming in lung cancer
BibTeX
@article{wang2026metabolic,
title = {{Metabolic signature of phosphoethanolamine and arginine pathways predicts prognosis and immunotherapy resistance in lung adenocarcinoma}},
author = {Tao Wang and Hongwei Li and Fei Ding},
journal = {Translational cancer research},
year = {2026},
month = aug,
url = {https://europepmc.org/article/PMC/PMC13657820},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Metabolic signature of phosphoethanolamine and arginine pathways predicts prognosis and immunotherapy resistance in lung adenocarcinoma
AU - Tao Wang
AU - Hongwei Li
AU - Fei Ding
PY - 2026
DA - 2026/08/13
JO - Translational cancer research
UR - https://europepmc.org/article/PMC/PMC13657820
SN - 2218-676X
ER -